Balance between survivin, a key member of the apoptosis inhibitor family, and its specific antibodies determines erosivity in rheumatoid arthritis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1478-6354
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Balance between survivin, a key member of the apoptosis inhibitor family, and its specific antibodies determines erosivity in rheumatoid arthritis ; volume:7 ; number:2 ; day:21 ; month:1 ; year:2005 ; pages:1-10 ; date:12.2005
Arthritis Research & Therapy ; 7, Heft 2 (21.1.2005), 1-10, 12.2005
- Creator
-
Bokarewa, Maria
- Contributor
-
Lindblad, Sofia
Bokarew, Dmitriy
Tarkowski, Andrej
SpringerLink (Online service)
- DOI
-
10.1186/ar1498
- URN
-
urn:nbn:de:1111-201605032025
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:47 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Bokarewa, Maria
- Lindblad, Sofia
- Bokarew, Dmitriy
- Tarkowski, Andrej
- SpringerLink (Online service)
Other Objects (12)
Serum and synovial survivin in rheumatoid arthritis: Relation to disease activity and severity
Novel EGFR family member binding antibodies as cancer therapeutics
Smoking in combination with antibodies to cyclic citrullinated peptides is associated with persistently high levels of survivin in early rheumatoid arthritis: a prospective cohort study
Survivin 2α: a novel Survivin splice variant expressed in human malignancies
Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin
Role of serum survivin as a predictor of response to biological treatment in rheumatoid arthritis patients
Potential therapeutic antibodies targeting specific adiponectin isoforms in rheumatoid arthritis
Assessment of serum antimutated citrullinated vimentin antibodies in rheumatoid arthritis
Funktionelle Charakterisierung neuer Survivin-Exportinhibitoren
Wachstumsverhalten von Glioblastomzellen nach Transduktion der Gene für Survivin und für eine Survivin-Mutante
Survivin and caspases serum protein levels and survivin variants mRNA expression in sepsis
Serum rheumatoid factor IgA, anti-citrullinated peptide antibodies with secretory components, and anti-carbamylated protein antibodies associate with interstitial lung disease in rheumatoid arthritis
Serum and synovial survivin in rheumatoid arthritis: Relation to disease activity and severity
Novel EGFR family member binding antibodies as cancer therapeutics
Smoking in combination with antibodies to cyclic citrullinated peptides is associated with persistently high levels of survivin in early rheumatoid arthritis: a prospective cohort study
Survivin 2α: a novel Survivin splice variant expressed in human malignancies
Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin
Role of serum survivin as a predictor of response to biological treatment in rheumatoid arthritis patients
Potential therapeutic antibodies targeting specific adiponectin isoforms in rheumatoid arthritis
Assessment of serum antimutated citrullinated vimentin antibodies in rheumatoid arthritis
Funktionelle Charakterisierung neuer Survivin-Exportinhibitoren
Wachstumsverhalten von Glioblastomzellen nach Transduktion der Gene für Survivin und für eine Survivin-Mutante
Survivin and caspases serum protein levels and survivin variants mRNA expression in sepsis
Serum rheumatoid factor IgA, anti-citrullinated peptide antibodies with secretory components, and anti-carbamylated protein antibodies associate with interstitial lung disease in rheumatoid arthritis
Serum and synovial survivin in rheumatoid arthritis: Relation to disease activity and severity
Novel EGFR family member binding antibodies as cancer therapeutics
Smoking in combination with antibodies to cyclic citrullinated peptides is associated with persistently high levels of survivin in early rheumatoid arthritis: a prospective cohort study
Survivin 2α: a novel Survivin splice variant expressed in human malignancies
Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin
Role of serum survivin as a predictor of response to biological treatment in rheumatoid arthritis patients
Potential therapeutic antibodies targeting specific adiponectin isoforms in rheumatoid arthritis
Assessment of serum antimutated citrullinated vimentin antibodies in rheumatoid arthritis
Funktionelle Charakterisierung neuer Survivin-Exportinhibitoren
Wachstumsverhalten von Glioblastomzellen nach Transduktion der Gene für Survivin und für eine Survivin-Mutante
Survivin and caspases serum protein levels and survivin variants mRNA expression in sepsis